NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NCT06402565)
A Randomized, Controlled, Evaluator-Blinded Study to Assess the Safety and Efficacy of NOX1416 in the Treatment of Chronic, Non-Healing, Diabetic Foot Ulcers
π©Ί Plain-English Summary (8th-Grade Level)
The goal of this multi-center, randomized, controlled, evaluator-blinded study is to assess and measure the safety and efficacy of NOX1416 as an adjunct to standard of care (SOC) in the treatment of chronic, non-healing, diabetic foot ulcers (DFUs). Subjects will be randomized to receive treatment with NOX1416 as an adjunct to Standard of Care (SOC) or SOC alone. The primary objective of the study is to demonstrate the safety and tolerability of NOX1416 as adjunct to SOC. The secondary objective of the study is to evaluate the clinical benefit of daily NOX1416, as an adjunct to SOC, in the treatment of chronic, non-healing diabetic foot ulcers. The study will use a centralized blinded assessor. The blinded assessor will be responsible for assessing the efficacy endpoints such as wound measurements and complete wound closure. The blinded assessor will not be involved in the clinical care of the subject.
Who can join: Review the eligibility criteria below.
Location: Advanced Foot Care β Phoenix, Arizona
Age range: 18 Years to 80 Years
π§ͺ Interventions in This Study
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (13 Sites)
- Advanced Foot Care β Phoenix, Arizona
- AFC - Tucson β Tucson, Arizona
- Solutions Medical Research β Coral Gables, Florida
- Prohealth Research Center β Doral, Florida
- Betancourt Research Services β Doral, Florida
- Family First Medical Research Center β Hialeah Gardens, Florida
- Symphony β Palm Harbor, Florida
- Avita Clinical Research β Tampa, Florida
- Clinical Trials of New England β Hyde Park, Massachusetts
- Cutting Edge β Circleville, Ohio
- IntraCare Clinical β Dallas, Texas
- New Dawn Wellness and Medical Center β Houston, Texas
- RITE Clinicals β Shenandoah, Texas
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetic Foot Ulcer
- Omega3 Wound Fish Skin Graft in the Treatment of DFUs β Coconut Creek, Florida
- At-Home Exercise Study for Veterans With Healed Diabetic Foot Ulcers β Baltimore, Maryland
- A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot β San Francisco, California
- Efficacy of ProgenaMatrixβ’ in the Management of DFUs β Puyallup, Washington
- Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management β Palm Springs, California
Explore by condition: All Diabetic Foot Ulcer clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.